Peace Longe
- Indexed articles, last 90 days
- 120
- Latest publication
- Sep 22, 2026
- Outlet visibility, for yahoo.com
- Top 1K sites
- Earliest in this view
- Jul 4, 2026
Latest articles
JPMorgan strongly recommends buying tumbling energy leader (opens the original)
Read excerpt
NexGen Energy (NXE) has dropped close to 15% in the past six months, even as long-term uranium prices stayed near multi-year highs and utilities across the United States and Europe kept signing new nuclear supply contracts. JPMorgan just opened coverage of the Canadian uranium developer on Monday, Sept. 21. The bank told clients that NexGen's flagship Rook I project offers a scale and grade that few others can match. JPMorgan also mentioned that Wall Street is not yet accounting for that project
BofA sends strong verdict on grocer making healthy food affordable (opens the original)
Read excerpt
Grocery bills have stayed high for American households, and shoppers keep searching for stores that offer good prices for healthy food. One of Wall Street's most respected firms thinks a family-run grocer fits that description. Bank of America started coverage of Natural Grocers by Vitamin Cottage (NGVC) with a Buy rating and a $35 price target, which points to roughly 20% gains from where the stock closed on Sept. 18. Shares increased 5.66% that day to $30.98, adding to a 25.43% run so far in 2
Why Morgan Stanley likes Gilead's HIV prevention play (opens the original)
Read excerpt
Morgan Stanley met privately with Gilead Sciences (GILD) leadership at its 2026 Global Healthcare Conference this month, and the feedback strengthened the bank's positive view on the stock. Morgan Stanley's biopharma team hosted a meeting and a management dinner with Gilead Chairman and CEO Daniel O'Day and Chief Commercial and Corporate Affairs Officer Johanna Mercier. According to a Morgan Stanley research note shared with me, the discussion reinforced its Overweight rating on Gilead and singl
Salesforce unveils AIforce as Benioff takes shot at Microsoft (opens the original)
Read excerpt
Salesforce (CRM) CEO Marc Benioff just made a product announcement at Dreamforce 2026, and he used the stage to directly criticize Microsoft in the process. The product is called AIforce, an AI connectivity layer that lets employees access Salesforce data and run complex workflows inside third-party AI tools such as Anthropic's Claude and Slack. CRM stock has rallied about 34% over the past month after a difficult start to 2026, and the stock closed at $255.65 on Sept. 15. The Dreamforce announc
Top analyst strongly resets General Motors target before earnings (opens the original)
Read excerpt
General Motors (GM) is known for its pickups and SUVs, and UBS significantly adjusted its price target on the stock days before the company reports earnings, claiming investors have overlooked an important part of the business. The bank believes the shares have a chance to move way higher than today's price. General Motors investors and prospective buyers now have to decide whether the reason for the call is valid enough. UBS analyst Joseph Spak raised his price target on General Motors to $114
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 1K sites
For yahoo.com, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.